Log in

NYSE:KODKodiak Sciences Stock Price, Forecast & News

$50.35
+1.76 (+3.62 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$49.75
Now: $50.35
$52.62
50-Day Range
$48.59
MA: $59.97
$66.25
52-Week Range
$9.47
Now: $50.35
$82.75
Volume376,800 shs
Average Volume362,696 shs
Market Capitalization$2.24 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat ophthalmic diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biologic that is in Phase I clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidates include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases; KSI-201, a recombinant mammalian cell expressed dual inhibitor antibody biopolymer bioconjugate for the treatment of wet AMD; and KSI-401, a recombinant mammalian cell expressed antibody biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.19 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone650-281-0850

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$2.24 billion
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive KOD News and Ratings via Email

Sign-up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter.

Kodiak Sciences (NYSE:KOD) Frequently Asked Questions

How has Kodiak Sciences' stock been impacted by COVID-19 (Coronavirus)?

Kodiak Sciences' stock was trading at $53.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, KOD shares have decreased by 6.5% and is now trading at $50.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Kodiak Sciences?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kodiak Sciences in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Kodiak Sciences.

When is Kodiak Sciences' next earnings date?

Kodiak Sciences is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Kodiak Sciences.

How were Kodiak Sciences' earnings last quarter?

Kodiak Sciences Inc. (NYSE:KOD) issued its quarterly earnings data on Monday, May, 11th. The company reported ($0.54) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.47) by $0.07. View Kodiak Sciences' earnings history.

What price target have analysts set for KOD?

10 analysts have issued 1-year target prices for Kodiak Sciences' shares. Their forecasts range from $40.00 to $115.00. On average, they expect Kodiak Sciences' share price to reach $83.00 in the next twelve months. This suggests a possible upside of 64.8% from the stock's current price. View analysts' price targets for Kodiak Sciences.

Has Kodiak Sciences been receiving favorable news coverage?

Headlines about KOD stock have trended negative this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Kodiak Sciences earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Kodiak Sciences.

Who are some of Kodiak Sciences' key competitors?

What other stocks do shareholders of Kodiak Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kodiak Sciences investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), NVIDIA (NVDA), Alibaba Group (BABA), Cisco Systems (CSCO), Inovio Pharmaceuticals (INO), Square (SQ), AT&T (T), Walt Disney (DIS) and CVS Health (CVS).

Who are Kodiak Sciences' key executives?

Kodiak Sciences' management team includes the following people:
  • Dr. Victor Perlroth, Co-Founder, Chairman, CEO & Pres (Age 45)
  • Mr. John A. Borgeson MBA, CPA, Sr. VP & CFO (Age 57)
  • Dr. Hong Liang, Sr. VP of Discovery Medicine (Age 46)
  • Dr. Jason S. Ehrlich M.D., Ph.D., Chief Medical Officer & Chief Devel. Officer (Age 42)
  • Dr. Joel Naor M.D., MSc, MBA, VP of Clinical R&D Operations

When did Kodiak Sciences IPO?

(KOD) raised $126 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 9,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Barclays and Chardan were co-managers.

What is Kodiak Sciences' stock symbol?

Kodiak Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "KOD."

How do I buy shares of Kodiak Sciences?

Shares of KOD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Kodiak Sciences' stock price today?

One share of KOD stock can currently be purchased for approximately $50.35.

How big of a company is Kodiak Sciences?

Kodiak Sciences has a market capitalization of $2.24 billion.

What is Kodiak Sciences' official website?

The official website for Kodiak Sciences is www.kodiak.com.

How can I contact Kodiak Sciences?

The company can be reached via phone at 650-281-0850.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.